In this paper, the impact of increased information on brand name and generic pharmaceutical prices is analyzed both theoretically and empirically. The theoretical results show that an increase in information is likely to reduce the price of brand name pharmaceuticals, while the results regarding generics are less clear. In the empirical part of the paper, the introduction of the substitution reform in the Swedish pharmaceuticals market in October 2002 is used as a natural experiment regarding the effects of increased consumer information on pharmaceutical prices. The results clearly show that the reform has lowered the price of both brand name- and generic pharmaceuticals.Pharmaceutical industry; generic competition; generic drugs; brand na...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
We study the impact of regulation on competition between brand-names and generics and pharmaceutical...
We study the short- and long-term price effects of the number of competing firms, using panel-data o...
In this paper, the impact of increased consumer information on brand name and generic pharmaceutical...
The impact of a reform that increased consumer information on brand name and generic pharmaceutical ...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
In October 2002 a substitution reform was introduced in the Swedish Pharmaceuticals market. In this ...
The present paper evaluates the quantitative impact of a pharmaceutical reform on pharmaceutical pr...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmac...
Reference pricing is one of the most common regulatory tools used to promote competition between pha...
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a ...
In 2009, the Swedish pharmaceuticals market was reformed. One of the stated policygoals was to achie...
This paper examines the price effects of generic drugs that are produced by brand-name drug firms an...
Empirical studies suggest that entry of generic competitors results in minimal decreases or even inc...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
We study the impact of regulation on competition between brand-names and generics and pharmaceutical...
We study the short- and long-term price effects of the number of competing firms, using panel-data o...
In this paper, the impact of increased consumer information on brand name and generic pharmaceutical...
The impact of a reform that increased consumer information on brand name and generic pharmaceutical ...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
The price effects of the Swedish pharmaceutical substitution reform are analyzed using data for a pa...
In October 2002 a substitution reform was introduced in the Swedish Pharmaceuticals market. In this ...
The present paper evaluates the quantitative impact of a pharmaceutical reform on pharmaceutical pr...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharmac...
Reference pricing is one of the most common regulatory tools used to promote competition between pha...
We study the impact of regulatory regimes on generic competition and pharmaceutical pricing using a ...
In 2009, the Swedish pharmaceuticals market was reformed. One of the stated policygoals was to achie...
This paper examines the price effects of generic drugs that are produced by brand-name drug firms an...
Empirical studies suggest that entry of generic competitors results in minimal decreases or even inc...
In this paper we study the impact of reference pricing (RP) on entry of generic firms in the pharma...
We study the impact of regulation on competition between brand-names and generics and pharmaceutical...
We study the short- and long-term price effects of the number of competing firms, using panel-data o...
Add to ORKG